Clinical Management of Thyroid Disease is an exciting new book edited by Fredric Wondisford, MD-developer of the revolutionary new drug, Thyrotropin-and Sally Radovick, MD, with contributions from experts in the field. It fulfills the niche of a succinct, clinical resource to help you translate research into practice. This full-color volume offers valuable information on thyroid cancer and non-cancerous lesions, the effect of drugs on thyroid function, genetic disorders, and more in an accessible, easy-to-read consistent format.
Presents the expertise of authors and editorial staff comprised of leaders in the field of thyroid research and clinical management for the best-qualified guidance on diagnosis and treatment.
Provides a full-color, comprehensive approach that makes valuable information easy to locate and quick to read.
Covers relevant topics applicable to all levels of training and expertise to serve as a detailed clinical reference on everything from the basic to the sophisticated.
Captures research advances on hot topics such as thyroid cancer and non-cancerous lesions, the effect of drugs on thyroid function, and genetic disorders so that you can incorporate them into the way you treat patients.
Edited by Fredric E. Wondisford, MD, Professor and Chief Metabolism Divsion Pediatrice, Medicine and Physiology Departments, Director Research and Training Center; Johns Hopkins University School of Medicine, Baltimore, MD
Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. With titles available across a variety of media—print, online and mobile, we are able to supply the information you need in the most convenient format.